Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug
Seeking Alpha
Wed, 02/29/12 - 11:04 am
Tags:
Arena Pharmaceuticals, lorcaserin, Vivus, Qnexa, obesity
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wed, 02/29/12 - 10:12 am
Tags:
obesity, M&A, Vivus, Qnexa, JNJ, Merck, Bristol-Myers Squibb, Arena Pharmaceuticals, Orexigen
Vivus's Qnexa And Its Potential Value
Seeking Alpha
Sat, 02/25/12 - 09:23 am
Tags:
Vivus, Qnexa, obesity, weight loss
Vivus Drug Won't Solve U.S. Weight Woes, Says Author (video)
The Street
Sat, 02/25/12 - 09:14 am
Tags:
Vivus, Qnexa
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
Seeking Alpha
Fri, 02/24/12 - 09:59 am
Tags:
Qnexa, Vivus, obesity, Arena Pharmaceuticals, Orexigen
Vivus rockets 99% on FDA nod
Marketwatch
Thu, 02/23/12 - 10:41 am
Tags:
FDA, Vivus, obesity, Qnexa
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
Washington Post, DC
Wed, 02/22/12 - 10:12 pm
Tags:
FDA, Vivus, obesity, Qnexa, advisory panel
Vivus: FDA Panel Live Blog
TheStreet.com
Wed, 02/22/12 - 08:08 am
Tags:
FDA, Vivus, obesity, advisory panel, Qnexa
Opportunity In The Weight Loss Drug Market
Seeking Alpha
Tue, 02/21/12 - 07:19 pm
Tags:
obesity, Vivus, Qnexa, Abbott Laboratories, Alkermes, GSK, JNJ, Roche, Orexigen
A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer'
TheStreet.com
Tue, 02/21/12 - 10:44 am
Tags:
obesity, Vivus, advisory panel, FDA, Qnexa
No Way? Obesity Drugs Have Side Effects
Motley Fool
Sat, 02/18/12 - 12:11 pm
Tags:
Vivus, obesity, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Vivus obesity drug has safety risks-US FDA staff
Reuters
Fri, 02/17/12 - 09:12 am
Tags:
Vivus, obesity, FDA, Qnexa
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
TheStreet.com
Fri, 02/17/12 - 09:05 am
Tags:
Vivus, Chelsea Therapeutics, Keryx, Biocryst, Exelixis, BioSante
3 Highly Shorted Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Thu, 02/16/12 - 11:22 am
Tags:
Vivus, Seattle Genetics, Amyris
The Skinny on Upcoming Obesity FDA Meetings
Motley Fool
Sat, 02/11/12 - 11:44 am
Tags:
Vivus, Qnexa, Arena Pharmaceuticals, lorcaserin, pixantrone, Cell Therapeutics, obesity, weight loss
3 Biotech Companies Down But Not Out
Seeking Alpha
Wed, 02/8/12 - 09:34 am
Tags:
Arena, Vivus, Orexigen, Biocryst, BioSante
Small Pharma With Big Compounds: Final Dance With The FDA
Seeking Alpha
Mon, 02/6/12 - 09:42 am
Tags:
GSK, AstraZeneca, FDA, Eli Lilly, Pfizer, Vivus, Merck, MAP Pharmaceuticals
FDA Pharma Meetings for February
Motley Fool
Tue, 01/31/12 - 07:58 am
Tags:
FDA, Amgen, Xgeva, Cell Therapeutics, Pixuvri, Vivus, Qnexa, Chelsea Therapeutics, Northera
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Minyanville
Fri, 01/13/12 - 10:26 am
Tags:
Vivus, Arena, Orexigen, obesity, lorcaserin, Qnexa, Contrave
Vivus obesity drug may get broader label
Reuters
Mon, 01/9/12 - 10:30 am
Tags:
obesity, Vivus, Qnexa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.